G
Generation Bio Co D
D
GBIO
0.35320
USD
-0.03
(-7.25%)
مغلق
حجم التداول
11,797
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
23,676,845
الأخبار المقالات
العنوان: Generation Bio Co
القطاع: Healthcare
الصناعة: Biotechnology
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform isits novel iqDNA, which is an optimized variant of its ceDNA.